Onglyza Oral Tablet 2.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Onglyza: Oral tablet (2.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_18814.JPG
Onglyza 2.5mg Tab
AstraZeneca Pharmaceuticals LP
Pill Identification: 4214  |  2.5
Drug Image file DrugItem_18814.JPG
Onglyza 2.5mg Tab
AstraZeneca Pharmaceuticals LP
Pill Identification: 4214  |  2.5

What is this Medicine?

SAXAGLIPTIN (SAX a glip tin) helps to treat type 2 diabetes. It helps to control blood sugar. Treatment is combined with diet and exercise.

CVS Pharmacy Patient Statistics for Onglyza: Oral tablet(2.5mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Onglyza 2.5mg Tablet

NDC: 000034214
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Type 2 Diabetes Mellitus

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Onglyza 2.5mg Tablet
Drug Image file DrugItem_15157.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: 4214  |  2.5
Shape: round
Color: yellow
Drug Image file DrugItem_18814.JPG
AstraZeneca Pharmaceuticals LP
Pill Identification: 4214  |  2.5
Shape: round
Color: yellow

Reported Side Effects for Onglyza 2.5mg Tablet

Infection Incidence:
0.1-7.7%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
0.2-1.5%*
Severity: MILD
Onset: EARLY
Low Lymphocytes Incidence:
0.5-1.5%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
1.5%*
Severity: MILD
Onset: RAPID
Low Blood Sugar Incidence:
1.6-5.6%*
Severity: MODERATE
Onset: EARLY
Stomach Pain Incidence:
1.7-2.4%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
2.0-3.6%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
2.2-2.3%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
2.6-2.9%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
6.5%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
6.9%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Onglyza 2.5mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Alcohol and Onglyza 2.5mg Tablet(Saxagliptin)
Alcohol and Saxagliptin(Saxagliptin)
Ethanol may interfere with the actions of Antidiabetic agents. Alcoholic beverages can increase the risk of low blood sugar, or can cause increased blood sugar due to the calories in these beverages. Limit alcohol containing medicines and beverages if you are on Antidiabetic Agents. You should also learn how to recognize the signs of low blood sugar.
Minor Lifestyle Interaction
Grapefruit juice and Onglyza 2.5mg Tablet(Saxagliptin)
Grapefruit juice and Saxagliptin(Saxagliptin)
Saxagliptin and grapefruit juice may be taken together. Tell your healthcare professional about any unusual symptom that occurs.
Minor Lifestyle Interaction
Tobacco and Onglyza 2.5mg Tablet(Saxagliptin)
Tobacco and Saxagliptin(Saxagliptin)
If you use tobacco or are trying to quit tobacco use, you may need to monitor your blood sugar more frequently. Nicotine, a component of tobacco, can increase the blood sugar. Also, if you are trying to quit smoking, as your body adjusts to not smoking, your blood sugar levels may change; the action of saxagliptin may be increased and this could lead to low blood sugar. Know the symptoms of low or high blood sugar and report them if they occur. Monitor your blood sugar regularly.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Onglyza

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5